Publications by authors named "Thomas H Howard"

Claim this Profile
N
Novel CUBN Mutation in a Young Child With Megaloblastic Anemia.
Corey Falcon, Austin J Hamm, Geling Li, Jeffrey Lebensburger, Thomas H Howard

J Pediatr Hematol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Isolated Neutropenia Referred to Pediatric Hematology-Oncology Clinic.
Vishnu Nagalapuram, David McCall, Prasannalaxmi Palabindela, Thomas H Howard, Christina Bemrich-Stolz

Pediatrics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
Jason Payne, Inmaculada Aban, Lee M Hilliard, Jennifer Madison, Christina Bemrich-Stolz, Thomas H Howard

Pediatr Blood Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cell transfusion therapy for sickle cell patients with frequent painful events.
Lee M Hilliard, Varsha Kulkarni, Bisakha Sen, Cathy Caldwell, Christina Bemrich-Stolz, Thomas H Howard

Pediatr Blood Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of severe chronic pain with methadone in pediatric patients with sickle cell disease.
Zachary LeBlanc, Chris Vance, Jason Payne, Jie Zhang, Lee Hilliard, Thomas H Howard

Pediatr Blood Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
Jeffrey D Lebensburger, Gary R Cutter, Thomas H Howard, Paul Muntner, Daniel I Feig

Pediatr Nephrol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure.
Corey P Falcon, Thomas H Howard

Blood· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective cholecystectomy reduces morbidity of cholelithiasis in pediatric sickle cell disease.
Emily F Goodwin, Paige I Partain, Jeffrey D Lebensburger, Naomi S Fineberg, Thomas H Howard

Pediatr Blood Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe anemia early in life as a risk factor for sickle-cell kidney disease.
Inmaculada Aban, Sujatha Baddam, Lee M Hilliard, Thomas H Howard, Daniel I Feig

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.
Jeffrey D Lebensburger, Prasannalaxmi Palabindela, Thomas H Howard, Daniel I Feig, Inmaculada Aban

Pediatr Nephrol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
Jeremie H Estepp, Chiara Melloni, Courtney D Thornburg, Paweł Wiczling, Zora Rogers, Thomas H Howard

J Clin Pharmacol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.
Jeffrey D Lebensburger, Lee M Hilliard, Lauren E Pair, Robert Oster, Thomas H Howard

Clin Trials· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.
Jeffrey D Lebensburger, Rakeshkumar J Patel, Prasannalaxmi Palabindela, Christina J Bemrich-Stolz, Thomas H Howard

J Blood Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Christoph J Griessenauer, Jeffrey D Lebensburger, Michelle H Chua, Winfield S Fisher, Lee Hilliard, Thomas H Howard

J Neurosurg Pediatr· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered approach to designing sickle cell transition education.
Courtney P Williams, Catherine H Smith, Kristen Osborn, Christina J Bemrich-Stolz, Lee M Hilliard, Thomas H Howard

J Pediatr Hematol Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.
Allison A King, Mark J Rodeghier, Julie Ann Panepinto, John J Strouse, James F Casella, Thomas H Howard

Am J Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
Michael R DeBaun, Mae Gordon, Robert C McKinstry, Michael J Noetzel, Desiree A White, Thomas H Howard

N Engl J Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea.
Jeffrey D Lebensburger, Robert F Sidonio, Michael R Debaun, Monika M Safford, Thomas H Howard

Pediatr Blood Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.
Jeffrey D Lebensburger, Scott T Miller, Thomas H Howard, James F Casella, R Clark Brown

Pediatr Blood Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers in transition from pediatrics to adult medicine in sickle cell anemia.
Jeffrey D Lebensburger, Christina J Bemrich-Stolz, Thomas H Howard

J Blood Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.
Michael R DeBaun, Sharada A Sarnaik, Mark J Rodeghier, Caterina P Minniti, Thomas H Howard

Blood· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory and clinical correlates for magnetic resonance imaging (MRI) abnormalities in pediatric sickle cell anemia.
Jeffrey D Lebensburger, Lee M Hilliard, Tony M McGrath, Naomi S Fineberg, Thomas H Howard

J Child Neurol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
Jeffrey Lebensburger, Stephen M Johnson, David J Askenazi, Nigel L Rozario, Thomas H Howard

Am J Hematol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
Winfred C Wang, Russell E Ware, Scott T Miller, Rathi V Iyer, James F Casella, Thomas H Howard

Lancet· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of the silent cerebral infarct transfusion (SIT) trial.
James F Casella, Allison A King, Bruce Barton, Desiree A White, Michael J Noetzel, Thomas H Howard

Pediatr Hematol Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis